Re-GTC Biotherapeutics Grants EXPANDED License to PharmAthene for Further Development of Protexia(R)
Who knows this has been Ashley Lawton's first contribution to GTCB. I feel much better, now that I know that GTCB's Intellectual Property will not be given away like they have given away major part of the first 100 million shares.